Human CYP4B1 Gene in the Japanese Population Analyzed by Denaturing HPLC

Nhamburo, 1989, Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping, Biochemistry, 28, 8060, 10.1021/bi00446a014 Yokotani, 1990, cDNA cloning of cytochrome P-450 related to P-450p-2 from the cDNA library of human placenta, Eur. J. Biochem., 187, 23, 10.1111/j.1432-1033.1990.tb15273.x Imaoka, 2000, CYP4B1 is a possible risk factor for bladder cancer in humans, Biochem. Biophys. Res. Commun., 277, 776, 10.1006/bbrc.2000.3740 Robertson, 1983, The relationship between increases in the hepatic content of cytochrome P450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with Phenobarbital, Mol. Pharmacol., 24, 156 Smith, 1995, 4-Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1, Biochem. Pharmacol., 50, 1567, 10.1016/0006-2952(95)02029-2 Robertson, 1986, The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene, Mutat. Res., 175, 153, 10.1016/0165-7992(86)90115-6 Vanderslice, 1985, The cytochrome P-450 monooxygenase system of rabbit bladder mucosa: enzyme components and isozyme 5-dependent metabolism of 2-aminofluorene, Cancer Res., 45, 5851 Lo-Guidice, 2002, Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant, Pharmacogenetics, 12, 367, 10.1097/00008571-200207000-00004 Frueh, 2003, The use of denaturing high-performance liquid chromatography (DHPLC) for the analysis of genetic variations: impact for diagnostics and pharmacogenetics, Clin. Chem. Lab. Med., 41, 452, 10.1515/CCLM.2003.068 Yu, 1994, Acetylator phenotype, aminobiphenylhemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles California, J. Natl. Cancer Inst., 86, 712, 10.1093/jnci/86.9.712